SignalTrace

Oral Antihistamines

John Montgomery4 min read

Oral Antihistamines

Oral H1 antihistamines block histamine at H1 receptors. Sedating first-generation drugs (Chlorphenamine, diphenhydramine/“Benadryl”, promethazine, hydroxyzine) cross into the brain. Non-sedating second-generation drugs (cetirizine, loratadine, fexofenadine) largely do not. Doctors and parents often reach for them because eczema itches. But eczema itch is driven mainly by non-histamine mediators, so Eczema UK and the National Eczema Association both say antihistamines do not reduce atopic eczema itch. Any sedating use in toddlers is a short-term sleep aid on medical advice, not an eczema treatment.

Oral Antihistamines [relates] Itch-Scratch Cycle Oral Antihistamines [relates] Sleep Disturbance in Eczema

Evidence (Cochrane, Matterne 2019). The review covered 25 RCTs with 3,285 participants (8 trials, 1,941 children), testing 13 different H1 antihistamines added on top of creams and ointments. It found “no convincing evidence that H1 antihistamines help patients with eczema”. The trials were too varied to pool. The key paediatric trial gave 795 young children cetirizine 0.5 mg/kg/day for 18 months. SCORAD fell in both arms with no difference from placebo, though cetirizine was probably associated with slightly fewer, mostly mild, adverse events. In adults, cetirizine 10 mg and loratadine 10 mg showed no benefit. Fexofenadine 120 mg gave a small itch reduction that may not be clinically meaningful. Evidence was low to moderate certainty, and the authors judged the non-sedating drugs studied to be safe. No trial in the review tested sedating antihistamines for sleep in toddlers.

Cochrane [opposes] Oral Antihistamines Oral Antihistamines [relates] SCORAD

Guidelines. NICE CG57 says oral antihistamines should not be used routinely for atopic eczema in children. It allows two exceptions:

  • a 1-month trial of a non-sedating antihistamine in severe eczema, severe itch or urticaria;
  • a 7–14-day trial of a sedating antihistamine during flares for children aged 6 months and over, when sleep disruption is significant.

The British Association of Dermatologists leaflet likewise limits sedating antihistamines to short-term night-time use. The American Academy of Dermatology recommends against topical antihistamines.

NICE CG57 [regulates] Oral Antihistamines British Association of Dermatologists [regulates] Oral Antihistamines American Academy of Dermatology [relates] Oral Antihistamines

Toddler safety — sedating antihistamines. In 2009 the MHRA and Commission on Human Medicines ruled that over-the-counter cough and cold medicines containing chlorphenamine, diphenhydramine, promethazine, doxylamine, brompheniramine or triprolidine “should no longer be used in children under 6 years”. There was “no robust evidence” they worked and “some reports of harm” (MHRA Drug Safety Update, April 2009). That ruling covers OTC cough and cold use, not prescribed use for eczema or allergy. But it reflects the same drugs’ poor safety margin in small children. New Zealand’s Medsafe goes further. It states that sedating antihistamines are contraindicated under 2 years for all indications, and prefers non-sedating cetirizine or loratadine when an antihistamine is needed. Instead of sedation, young children can get paradoxical stimulation ranging “from excitation through to tremors, hallucinations and convulsions”. Excessive doses have caused respiratory depression, coma and death (Medsafe 2013, citing a 3-year-old with a serious neurological reaction to chlorphenamine).

Conflict: [NICE CG57] allows a 7–14-day sedating antihistamine trial for children aged 6 months and over with eczema-related sleep loss. [Medsafe Prescriber Update, March 2013] says sedating antihistamines are contraindicated in children under 2 years for all indications. Unresolved for toddlers aged 6–24 months — add to open_questions.

Sedating antihistamines in under-2s

Do not give OTC sedating antihistamines (e.g. Benadryl/diphenhydramine, Piriton/chlorphenamine, promethazine) to a toddler for eczema or sleep without a doctor’s advice. Wrong doses can cause agitation, fits or dangerous over-sedation. They do not treat the eczema itself.

MHRA [regulates] Oral Antihistamines Oral Antihistamines [relates] Chlorphenamine

What parents report (evidence: anecdotal). One r/eczema parent of an 18-month-old says “we have to give him Benadryl most nights before bed or he’ll wake up screaming with blood all over the crib”. Other posters report that antihistamines do not stop itch-driven sleeplessness. Both fit the Cochrane finding: antihistamines may sedate, but they do not control the eczema. Usernames were removed from the saved sources.

Connections

Graph View

Backlinks